A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of iCo-007 Intravitreal Injection in Subjects with Diffuse Diabetic Macular Edema has been completed and the trial is now closed.  We are no longer recruiting patients for this trial.

Further information about the trial is available at http://clinicaltrials.gov/ct2/show/NCT00886808.